Bhatt, N. B., Barau, C., Amin, A., Baudin, E., Meggi, B., Silva, C., . . . Taburet, A. M. (2014). Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment. American Society for Microbiology.
Chicago-stil citatBhatt, N. B., et al. Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment. American Society for Microbiology, 2014.
MLA-referensBhatt, N. B., et al. Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment. American Society for Microbiology, 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.